InnovAge (INNV) Stock Price, News & Analysis

Company Overview

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

Key Stats

• Today's Range: $4.19 to $4.39
• 50-Day Range: $2.63 to $4.22
• 52-Week Range: $2.60 to $6.69
• Volume: 43,596 shs
• Average Volume: 55,196 shs
• Market Capitalization: $565.70 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

INNV Stock Analysis - Frequently Asked Questions

How have INNV shares performed this year?

InnovAge's stock was trading at $3.93 at the start of the year. Since then, INNV shares have increased by 6.6% and is now trading at $4.19.
View the best growth stocks for 2025 here.

How were InnovAge's earnings last quarter?

InnovAge Holding Corp. (OTCMKTS:INNV) released its quarterly earnings results on Tuesday, November, 9th. The company reported $0.06 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.01. The firm earned $173.07 million during the quarter, compared to analysts' expectations of $173.13 million. InnovAge had a negative trailing twelve-month return on equity of 13.04% and a negative net margin of 6.17%.

How do I buy shares of InnovAge?

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of InnovAge own?

Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include EEStor Co. (ESU.V) (ESU), Antares Pharma (ATRS), Medicines (MDCO), Federal National Mortgage Association (FNMA), Frontier Communications (FTR), FedEx (FDX) and NVIDIA (NVDA).

Company Calendar

• Last Earnings: 11/09/2021
• Today: 5/16/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:INNV
• Previous Symbol: NASDAQ:INNV
• CIK: 1411879
• Web: www.innovuspharma.com
• Phone: 844-803-8745
• Fax: N/A
• Employees: 2,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.23)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-6,520,000.00
• Net Margins: -6.17%
• Pretax Margin: -7.63%
• Return on Equity: -13.04%
• Return on Assets: -7.48%

Debt

• Debt-to-Equity Ratio: 0.25
• Current Ratio: 1.57
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: $831.68 million
• Price / Sales: 0.68
• Cash Flow: $0.06 per share
• Price / Cash Flow: 65.41
• Book Value: $2.50 per share
• Price / Book: 1.68

Miscellaneous

• Outstanding Shares: 135,013,000
• Free Float: 135,311,000
• Market Cap: $565.70 million
• Optionable: Not Optionable
• Beta: 0.40